• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vet Microbiol . Recombinant probiotic Escherichia coli delivers the polymeric protein of swine influenza virus for protection

tetano

Editor, Senior Moderator
Vet Microbiol


. 2025 Jan 21:302:110401.
doi: 10.1016/j.vetmic.2025.110401. Online ahead of print. Recombinant probiotic Escherichia coli delivers the polymeric protein of swine influenza virus for protection

Jin-Mei Sun[SUP] 1 [/SUP], Wen-Qiang Zhang[SUP] 1 [/SUP], Yan-Jin Li[SUP] 1 [/SUP], Tian-Kui Guo[SUP] 1 [/SUP], Rong-Rong Zhang[SUP] 1 [/SUP], Yong-Lei Yang[SUP] 1 [/SUP], Ying Zhao[SUP] 1 [/SUP], Ling-Jiao Yu[SUP] 1 [/SUP], Chun-Wei Shi[SUP] 1 [/SUP], Gui-Lian Yang[SUP] 1 [/SUP], Hai-Bin Huang[SUP] 1 [/SUP], Yan-Long Jiang[SUP] 1 [/SUP], Jian-Zhong Wang[SUP] 1 [/SUP], Xin Cao[SUP] 1 [/SUP], Nan Wang[SUP] 1 [/SUP], Yan Zeng[SUP] 1 [/SUP], Wen-Tao Yang[SUP] 2 [/SUP], Chun-Feng Wang[SUP] 3 [/SUP]



Affiliations
Abstract

Swine influenza virus invades the host through the respiratory mucosa, which severely restricts the development of the pig breeding industry. To construct monomeric and trimeric vaccines, we developed recombinant Escherichia coli Nissle 1917 (EcN) strains that express the receptor binding site (RBS) of the hemagglutinin (HA) antigen from H1N1 swine influenza virus. After the mucosal immunization of mice, we found that probiotics activated CD40 and CD86 in DCs and increased the levels of IL-4 and IFN-γ secretion by T cells. Furthermore, the probiotics improved the function of the mucosal immune system, increased the level of SIgA, level of IgG and number of B220[SUP]+[/SUP]IgA[SUP]+[/SUP], and activated germinal center B cells. The challenge experiment revealed that the probiotics alleviated weight loss, reduced pathological injury to the lungs, and protected the mice from virus infection. We also observed that the serum neutralizing antibodies of immunized piglets significantly increased, which reduced the shedding frequency of swine influenza virus in the nose of the piglets and reduced the pathological damage by activating the T cell immune response in infected piglets. Thus, the constructed probiotics are promising candidates for effective non-traditional swine influenza vaccines.

Keywords: Animal experiment; Mucosal vaccine; Probiotics; RBS; Swine influenza virus.

 
Back
Top Bottom